{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:35Z","timestamp":1787027075192,"version":"build-2736575974"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2020.00519","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T01:04:20Z","timestamp":1599008660000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Azithromycin Prescribing by Respiratory Pediatricians in Australia and New Zealand for Chronic Wet Cough: A Questionnaire-Based Survey"],"prefix":"10.3389","volume":"8","author":[{"given":"Naomi","family":"Chellew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne B.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Grimwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S0140-6736(18)31554-X","article-title":"Bronchiectasis in children: diagnosis and treatment","volume":"392","author":"Chang","year":"2018","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fped.2017.00030","article-title":"Chronic suppurative lung disease in children: definition and spectrum of disease","volume":"5","author":"Redding","year":"2017","journal-title":"Front Pediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1378\/chest.11-2725","article-title":"A multi-centre study on chronic cough in children: burden and etiologies based on standardized management pathway","volume":"142","author":"Chang","year":"2012","journal-title":"Chest."},{"key":"B4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.pharmthera.2014.03.003","article-title":"Azithromycin: mechanism of action and their relevance for clinical applications","volume":"143","author":"Parnham","year":"2014","journal-title":"Pharmacol Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/ppul.23952","article-title":"Comparison of bronchoscopy and bronchoalveolar lavage findings in three types of suppurative lung disease","volume":"53","author":"De Vries","year":"2018","journal-title":"Pediatr Pulmonol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S2213-2600(13)70038-9","article-title":"Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases","volume":"1","author":"Serisier","year":"2013","journal-title":"Lancet Respir Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.5694\/j.1326-5377.2006.tb00290","article-title":"The Thoracic Society of Australia and New Zealand. Position statement. Cough in children: definitions and clinical evaluation","author":"Chang","year":"2006","journal-title":"Med J Aust"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1602139","DOI":"10.1183\/13993003.02139-2016","article-title":"ERS statement on protracted bacterial bronchitis in children","volume":"50","author":"Kantar","year":"2017","journal-title":"Eur Respir J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.chest.2017.01.025","article-title":"Management of children with chronic wet cough and protracted bacterial bronchitis. CHEST guideline and expert panel report","volume":"151","author":"Chang","year":"2017","journal-title":"Chest."},{"key":"B10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5694\/mja14.00287","article-title":"Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. Thoracic Society of Australia and New Zealand guidelines","volume":"202","author":"Chang","year":"2015","journal-title":"Med J Aust."},{"key":"B11","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S2213-2600(13)70185-1","article-title":"Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multi-centre, double-blind, randomised controlled trial","volume":"1","author":"Valery","year":"2013","journal-title":"Lancet Respir Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.chest.2016.08.1451","article-title":"Macrolides for clinically significant bronchiectasis in adults: who should receive this treatment?","volume":"150","author":"Hill","year":"2016","journal-title":"Chest."},{"key":"B13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/ppul.23931","article-title":"Defining lower airway bacterial infection in children with chronic endobronchial disorders","volume":"53","author":"Hare","year":"2018","journal-title":"Pediatr Pulmonol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ijantimicag.2009.05.008","article-title":"Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005","volume":"34","author":"Karlowksy","year":"2009","journal-title":"Int J Antimicrob Agents."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.chest.2016.06.030","article-title":"Protracted bacterial bronchitis in children: natural history and risk factors for bronchiectasis","volume":"150","author":"Wurzel","year":"2016","journal-title":"Chest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00431-016-2743-5","article-title":"Paediatric chronic suppurative lung disease: clinical characteristics and outcomes","volume":"175","author":"Goyal","year":"2016","journal-title":"Eur J Pediatr."},{"key":"B17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ppul.23380","article-title":"Pediatric bronchiectasis: no longer an orphan disease","volume":"51","author":"Goyal","year":"2016","journal-title":"Pediatr Pulmonol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S2213-2600(19)30254-1","article-title":"Efficacy of oral amoxicillin\u2013clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial","volume":"7","author":"Goyal","year":"2019","journal-title":"Lancet Respir Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0140-6736(18)31723-9","article-title":"Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multi-centre, double-blind, non-inferiority randomised controlled trial","volume":"392","author":"Goyal","year":"2018","journal-title":"Lancet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"iii1","DOI":"10.1136\/thx.2007.077370","article-title":"BTS guidelines: recommendations for the assessment and management of cough in children","volume":"63","author":"Shields","year":"2008","journal-title":"Thorax."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2016.05.025","article-title":"Long-term effects of azithromycin in patients with cystic fibrosis","volume":"117","author":"Samson","year":"2016","journal-title":"Respir Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00408-019-00280-x","article-title":"Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access driven?","volume":"197","author":"Visser","year":"2019","journal-title":"Lung."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1164\/rccm.201808-1462LE","article-title":"Azithromycin for early Pseudomonas infection in cystic fibrosis. The OPTIMIZE randomized trial","volume":"198","author":"Mayer-Hamblett","year":"2018","journal-title":"Am J Respir Crit Care Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s10096-015-2480-0","article-title":"Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo","volume":"34","author":"Hare","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1748-5908-6-26","article-title":"How can we improve guideline use? A conceptual framework of implementability","volume":"6","author":"Gagliardi","year":"2011","journal-title":"Implement Sci."},{"key":"B26","unstructured":"Why aren't doctors following guidelines?18\n            NelsonB\n          Hospitalist102016"},{"key":"B27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/0009922815587091","article-title":"Evaluating guideline-recommended antibiotics practices for childhood respiratory infections: is it time to consider case-base formats?","volume":"55","author":"Wright","year":"2016","journal-title":"Clin Pediatr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(17)31547-7","article-title":"Azithromycin in uncontrolled asthma","volume":"390","author":"Brusselle","year":"2017","journal-title":"Lancet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.chest.2015.12.036","article-title":"The effects of azithromycin in treatment-resistant cough: a randomized, double-blind, placebo-controlled trial","volume":"149","author":"Hodgson","year":"2016","journal-title":"Chest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12890-017-0437-z","article-title":"Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study","volume":"17","author":"Kawamura","year":"2017","journal-title":"BMC Pulm Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fped.2019.00249","article-title":"Infectious disease clinician's variation in the management of Pediatric Staphylococcus aureus bacteraemia and equipoise for clinical trials","volume":"7","author":"Campbell","year":"2019","journal-title":"Front Pediatr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/ppul.23351","article-title":"Protracted bacterial bronchitis: the last decade and the road ahead","volume":"51","author":"Chang","year":"2016","journal-title":"Pediatr Pulmonol."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2020.00519\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T01:04:23Z","timestamp":1599008663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2020.00519\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":32,"alternative-id":["10.3389\/fped.2020.00519"],"URL":"https:\/\/doi.org\/10.3389\/fped.2020.00519","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,2]]},"article-number":"519"}}